يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"bismuth citrate/dt [Drug Therapy]"', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1
    Electronic Resource

    المؤلفون: Lambert J.R., Dev A.T.

    مصطلحات الفهرس: diarrhea/si [Side Effect], disease association, drug choice, drug efficacy, drug potentiation, drug tolerability, dyspepsia/dt [Drug Therapy], dyspepsia/si [Side Effect], eradication therapy, gastritis/co [Complication], gastritis/et [Etiology], gastroduodenal ulcer/co [Complication], gastroduodenal ulcer/dt [Drug Therapy], gastroduodenal ulcer/et [Etiology], gastroduodenal ulcer/si [Side Effect], Gram negative infection/di [Diagnosis], Gram negative infection/dt [Drug Therapy], Gram negative infection/ep [Epidemiology], Gram negative infection/et [Etiology], Helicobacter pylori, histology, human, mucosa associated lymphoid tissue lymphoma/co [Complication], mucosa associated lymphoid tissue lymphoma/et [Etiology], nausea/si [Side Effect], pathogenesis, patient compliance, pseudomembranous colitis/si [Side Effect], review, serodiagnosis, side effect, stomach adenocarcinoma/co [Complication], stomach adenocarcinoma/et [Etiology], taste disorder/si [Side Effect], amoxicillin/cb [Drug Combination], amoxicillin/do [Drug Dose], amoxicillin/dt [Drug Therapy], bismuth/ae [Adverse Drug Reaction], bismuth/do [Drug Dose], bismuth/it [Drug Interaction], metronidazole/ae [Adverse Drug Reaction], metronidazole/cb [Drug Combination], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], nonsteroid antiinflammatory agent/ae [Adverse Drug Reaction], nonsteroid antiinflammatory agent/dt [Drug Therapy], omeprazole/cb [Drug Combination], omeprazole/do [Drug Dose], omeprazole/it [Drug Interaction], omeprazole/dt [Drug Therapy], pantoprazole/cb [Drug Combination], pantoprazole/do [Drug Dose], pantoprazole/dt [Drug Therapy], proton pump inhibitor/cb [Drug Combination], proton pump inhibitor/do [Drug Dose], proton pump inhibitor/it [Drug Interaction], proton pump inhibitor/dt [Drug Therapy], ranitidine bismuth citrate/do [Drug Dose], ranitidine bismuth citrate/dt [Drug Therapy], tetracycline/do [Drug Dose], tetracycline/dt [Drug Therapy], unclassified drug, urea/ec [Endogenous Compound], helidac/do [Drug Dose], helidac/dt [Drug Therapy], endoscope, bismuth/dt [Drug Therapy], bismuth citrate/do [Drug Dose], bismuth citrate/dt [Drug Therapy], clarithromycin/ae [Adverse Drug Reaction], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], histamine H2 receptor antagonist/dt [Drug Therapy], lansoprazole/cb [Drug Combination], lansoprazole/dt [Drug Therapy], antibiotic resistance, antibiotic therapy, breath analysis, carcinogenesis/co [Complication], clinical feature, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28480
    Medical Journal of Australia
    Click here for full text options
    LibKey Link

  2. 2
    Electronic Resource

    المؤلفون: Lambert J.R., Dev A.T.

    مصطلحات الفهرس: diarrhea/si [Side Effect], disease association, drug choice, drug efficacy, drug potentiation, drug tolerability, dyspepsia/dt [Drug Therapy], dyspepsia/si [Side Effect], eradication therapy, gastritis/co [Complication], gastritis/et [Etiology], gastroduodenal ulcer/co [Complication], gastroduodenal ulcer/dt [Drug Therapy], gastroduodenal ulcer/et [Etiology], gastroduodenal ulcer/si [Side Effect], Gram negative infection/di [Diagnosis], Gram negative infection/dt [Drug Therapy], Gram negative infection/ep [Epidemiology], Gram negative infection/et [Etiology], Helicobacter pylori, histology, human, mucosa associated lymphoid tissue lymphoma/co [Complication], mucosa associated lymphoid tissue lymphoma/et [Etiology], nausea/si [Side Effect], pathogenesis, patient compliance, pseudomembranous colitis/si [Side Effect], review, serodiagnosis, side effect, stomach adenocarcinoma/co [Complication], stomach adenocarcinoma/et [Etiology], taste disorder/si [Side Effect], amoxicillin/cb [Drug Combination], amoxicillin/do [Drug Dose], amoxicillin/dt [Drug Therapy], bismuth/ae [Adverse Drug Reaction], bismuth/do [Drug Dose], bismuth/it [Drug Interaction], metronidazole/ae [Adverse Drug Reaction], metronidazole/cb [Drug Combination], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], nonsteroid antiinflammatory agent/ae [Adverse Drug Reaction], nonsteroid antiinflammatory agent/dt [Drug Therapy], omeprazole/cb [Drug Combination], omeprazole/do [Drug Dose], omeprazole/it [Drug Interaction], omeprazole/dt [Drug Therapy], pantoprazole/cb [Drug Combination], pantoprazole/do [Drug Dose], pantoprazole/dt [Drug Therapy], proton pump inhibitor/cb [Drug Combination], proton pump inhibitor/do [Drug Dose], proton pump inhibitor/it [Drug Interaction], proton pump inhibitor/dt [Drug Therapy], ranitidine bismuth citrate/do [Drug Dose], ranitidine bismuth citrate/dt [Drug Therapy], tetracycline/do [Drug Dose], tetracycline/dt [Drug Therapy], unclassified drug, urea/ec [Endogenous Compound], helidac/do [Drug Dose], helidac/dt [Drug Therapy], endoscope, bismuth/dt [Drug Therapy], bismuth citrate/do [Drug Dose], bismuth citrate/dt [Drug Therapy], clarithromycin/ae [Adverse Drug Reaction], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], histamine H2 receptor antagonist/dt [Drug Therapy], lansoprazole/cb [Drug Combination], lansoprazole/dt [Drug Therapy], antibiotic resistance, antibiotic therapy, breath analysis, carcinogenesis/co [Complication], clinical feature, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28480
    Medical Journal of Australia
    LibKey Link

  3. 3
  4. 4
  5. 5
    Electronic Resource
  6. 6
  7. 7
  8. 8